biospecimen__admin__batch_number	327.54.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	371DEE73-57CB-4AF1-8971-0F1A4A3095E9
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A73E-01A-12R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A73E-01A-12
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A73E-01A
biospecimen__bio__biospecimen_barcode_bottom	0153879936
biospecimen__bio__day_of_creation	08
biospecimen__bio__day_of_shipment	25
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	08
biospecimen__bio__month_of_shipment	09
biospecimen__bio__pathology_report_file_name	TCGA-DD-A73E.10881D8D-1C62-4F3D-ACF6-36AD1F23B0A9.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A32J
biospecimen__bio__plate_row	H
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	2
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A73E
biospecimen__shared__patient_id	A73E
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	1D6979FB-94D4-45C8-835B-0F7E00D4A8BF
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.7
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.4
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.2
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	1
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Non-Alcoholic Fatty Liver Disease
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	9.5
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	13.8
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	11.5
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	66
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A73E-F66598
clinical__clin_shared__bcr_followup_uuid	FDB54AF8-2B1A-4773-9793-0580F2B42055
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	30
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	9
clinical__clin_shared__platelet_result_count	190
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	HBV Surface Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2012
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G1
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	e6a6a000-21ca-430a-b247-995593ea3120
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A73E-01A-12R-A32J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	8f241b2c-d241-4500-9225-1c32b593dc23
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.92
gdc__analytes__analyte_id	7fe0fdc8-1d4c-4fe4-8f6d-98cfa6e500b2
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	e0863874-f7b8-49b6-a88b-5ae5f1ec2b15
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:34:57.516354-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	97bfae54-b307-5c73-ab0b-7b10dc4e6a8a
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1946
gdc__diagnoses__age_at_diagnosis	24377
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24377.0
gdc__diagnoses__days_to_last_follow_up	44.0
gdc__diagnoses__diagnosis_id	ea0dc2b5-bf88-5d98-bd12-082caf49a1f7
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	36.50621957815035
gdc__exposures__exposure_id	588acf8b-92cd-50c6-b1cd-297e641c1813
gdc__exposures__height	172.0
gdc__exposures__weight	108.0
gdc__file_id	a754b539-c8cf-4fe9-90dd-a85938d56e6f
gdc__file_name	34f04a31-ce87-49c8-88a9-23761b370a79.mirbase21.mirnas.quantification.txt
gdc__file_size	50069
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	70acaf86fa7158b3d150defb3a545e9e
gdc__portions__is_ffpe	false
gdc__portions__portion_id	cfd1382a-4f79-44b3-a869-aae3b6043255
gdc__portions__portion_number	12
gdc__portions__weight	10.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	336
gdc__samples__initial_weight	170.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	10881D8D-1C62-4F3D-ACF6-36AD1F23B0A9
gdc__samples__sample_id	d4fcbd8f-0b83-4b9d-ac2c-ce8c47412cc3
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	6.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	6.0
gdc__slides__percent_tumor_cells	88.0
gdc__slides__percent_tumor_nuclei	92.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	83219588-13bc-457c-9239-7424c7400509
gdc__submitter_id	mirna_swap_dr11_199_MirnaExpression38474ec7-6048-4777-9297-ce623e9ae563_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	a1334f3f-67aa-5de9-bfb6-d0709467ca58
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:45.467+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/e6a6a000-21ca-430a-b247-995593ea3120-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/e6a6a000-21ca-430a-b247-995593ea3120-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129440
manually_curated__local_md5	5131f6b3b8d23e7745aa3b66869cc2bc
manually_curated__opengdc_download_date	2018-10-16T17:12:49.000814+02:00
manually_curated__opengdc_file_md5	9106cf5de2a0764038761e552fa44f6c
manually_curated__opengdc_file_size	50068
manually_curated__opengdc_id	e6a6a000-21ca-430a-b247-995593ea3120-meq
manually_curated__origin_file_size	129440
manually_curated__origin_last_modified_date	Tue Oct 16 17:15:00 CEST 2018
manually_curated__origin_md5	5131f6b3b8d23e7745aa3b66869cc2bc
manually_curated__tissue_status	tumoral
